Monday, September 19, 2016

BRIEF-Mabvax Therapeutics provides interim progress on programs

* Mabvax therapeutics reports on interim progress on its

programs including the phase i clinical trial for therapeutic

antibody treatment of pancreatic cancer

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)